By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tri-Institutional Therapeutics Discovery Institute 

413 E. 69th Street
Belfer Research Building
New York  New York  10021 
Phone: 646-962-6127 Fax: n/a


SEARCH JOBS

The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI). Tri-I TDI is a partnership of three world-renowned scientific and medical institutions — Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine. A novel partnership of academic institutions, the Tri-I TDI links researchers in basic and clinical science with experts in drug discovery from the biotech and pharmaceutical industries, with the goal of more efficiently translating discoveries into therapies for disease. Launched in 2013 in New York City the Tri-I TDI focuses on the early stages of developing compounds and biologic agents, and conducts “proof of concept” studies needed to demonstrate that drug candidates can successfully alter the course of a disease.

YEAR FOUNDED:

2013

LEADERSHIP:

Founder and CEO: Michael A. Foley

FOLLOW TRI-INSTITUTIONAL THERAPEUTCS DISCOVERY INSTITUTE:



Key Statistics


Email: info@tritdi.org
Ownership: Private

Web Site: Tri-Institutional Therapeutics Discovery Institute
Employees:
Symbol: 
 









Company News
//-->